Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

NCT02752204

Conditions
Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Royal Liverpool University Hospital Liverpool, United Kingdom
  • University College London Hospitals London, United Kingdom
  • Guys Hospital London, United Kingdom
View Trial Details
Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma

NCT00101010

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • CCOP - Grand Rapids Grand Rapids, Michigan, United States
  • CCOP - Kalamazoo Kalamazoo, Michigan, United States
  • Cancer Research for the Ozarks Springfield, Missouri, United States
View Trial Details
Completed

To Decrease Fatigue With Light Therapy

NCT03242902

Conditions
Diffuse Large B Cell Lymphoma, Dyssomnias, Hemic and Lymphatic Diseases, +17 more
Locations
  • Radboudumc Nijmegen, Gelderland, Netherlands
  • Netherlands Cancer Institute Amsterdam, North Holland, Netherlands
  • VUmc Amsterdam, North Holland, Netherlands
  • Leids Universitair Medisch Centrum Leiden, South Holland, Netherlands
View Trial Details
Completed

A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

NCT02343536

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions